<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250906067136N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-09-09</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparison of the Effectiveness of Neurofeedback and Yoga on Enhancing Concentration, Attention, and Reducing Anxiety in Children Aged 6 to 11 with Attention-Deficit/Hyperactivity Disorder (ADHD)</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effectiveness of Neurofeedback and Yoga on Enhancing Concentration, Attention, and Reducing Anxiety in Children Aged 6 to 11 with Attention-Deficit/Hyperactivity Disorder (ADHD)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86031</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: A simple randomization method will be used. According to this method, the names of all selected participants will be written on pieces of paper and placed in a box for a lottery draw. Then, the pieces of paper will be drawn one by one, with the first 25 participants (1–25) assigned to the experimental group and the next 25 participants (26–50) drawn from the box assigned to the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Attention-Deficit/Hyperactivity Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group will participate in a 24-session training program, each session lasting 60 minutes (30 minutes of neurofeedback + 30 minutes of yoga), conducted three times per week.    1. Sessions 1–3: Introduction and Initial AssessmentGoal: Reduce initial anxiety, familiarize children with the treatment process, and enhance motivation.Content:Neurofeedback: Baseline EEG assessment, introduction to the device, and simple games.Yoga: Introduction to yoga in child-friendly language, practice of abdominal breathing, and simple stretches.Homework: Daily 3-minute abdominal breathing exercise with parents.                                                                                                                                    2. Sessions 4–6: Beginning Basic TrainingGoal: Strengthen sustained attention and increase body awareness.Content:Neurofeedback: Implementation of SMR protocol (12–15 Hz), simple visual games.Yoga: Cat–cow, tree pose, and basic arm–leg stretches combined with calm breathing.Homework: Daily practice of the tree pose or a simple stretch at home.                                                                                                                                         3. Sessions 7–9: Stabilization and RelaxationGoal: Improve mental and physical self-regulation.Content:Neurofeedback: Continuation of SMR training with calm breathing before each session.Yoga: Focus on breathing and simple seated–standing movements.Homework: Daily 5-minute calm breathing practice with parents.                                                                  4. Sessions 10–12: Enhancing Selective AttentionGoal: Improve processing speed and focus on specific stimuli.Content:Neurofeedback: Introduction of low beta protocol (15–18 Hz), intermediate-level games.Yoga: Animal poses (frog, snake, bird) combined with storytelling.Homework: Practice one animal yoga pose at home and perform it for parents.                                                                                                             5. Sessions 13–15: Strengthening Sustained AttentionGoal: Enhance accuracy and mind–body control.Content:Neurofeedback: Combined SMR + beta protocol, more engaging games.Yoga: Balance exercises (tree pose, warrior, standing on one foot).Homework: Daily one-leg balance for 20 seconds.                                                                                                                         6. Sessions 16–18: Training in Simulated ConditionsGoal: Generalize learned skills to real-life situations.Content:Neurofeedback: Practice with distracting stimuli (additional sounds or images).Yoga: Guided relaxation (simple body scan, lying down, and breathing).Homework: Relaxation practice before bedtime (lying down and calm breathing).                                               7. Sessions 19–21: Review and IntegrationGoal: Automate attention and integrate mind–body skills.Content:Neurofeedback: Advanced-level games, focusing under more difficult conditions.Yoga: Integration of breathing, stretches, animal poses, and balance exercises.Homework: Short yoga session at home (5 minutes breathing + 2 simple poses).                               8. Sessions 22–24: Final ConsolidationGoal: Consolidate achievements and transfer skills into daily life.Content:Neurofeedback: Final review and training, reassessment of changes.Yoga: Review of learned movements, final playful yoga session.Homework: Continue daily practice (5 minutes breathing + one focus activity or yoga pose). Intervention 2: Control group: They receive no training.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Only part of the data, such as information related to the primary outcome or similar, can be shared.

When:
Access period begins 6 months after publication of results.

To whom:
The data will only be accessible to researchers affiliated with academic or scientific institutions.

Conditions:
Any type of analysis is permitted on the delivered data.

Where to obtain:
Via email: sogand.shahwar@aui.ir

How to obtain:
The data will be sent after emailing sogand shahwar and receiving approval from the research team members.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sogand Shahwar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 26, Arad 6 Building, Mehregan 4, Sepidar</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>617773751</zip>
        <telephone>+98 61 3227 1486</telephone>
        <email>sogand.shahwar@aui.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rahmatollah Khanmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Kargar Boulevard, Farhang Shahr District, Golestan Highway</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6134937333</zip>
        <telephone>+98 61 3334 8421</telephone>
        <email>info@iauahvaz.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Having a confirmed diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) by the school counselor as well as through ADHD questionnaires.
The child’s age should be between 6 and 11 years (completed).
Having an Intelligence Quotient (IQ) within the normal range (typically 90–110 or higher), as measured by the Wechsler Intelligence Scale for Children (WISC-IV).
No use of psychiatric medications during the past three months.
Obtaining written informed consent from the child’s parents for participation in the study.</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>11 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of severe comorbid psychiatric disorders or serious comorbid conditions such as psychotic disorders, severe major depressive disorder, bipolar disorder, or autism spectrum disorders.
Presence of neurophysiological disorders such as a history of epilepsy, seizures, severe head trauma, or any known neurological condition that may affect brain function and EEG.
Regular participation of the child in other psychotherapy sessions (such as play therapy, art therapy) or any other interventions that directly affect attention and anxiety during the study period.
Presence of severe sensory (blindness, deafness) or motor impairments that make participation in yoga sessions or sitting still during neurofeedback sessions impossible.
Lack of willingness of the child or family to consistently comply with the research protocol (regular attendance at sessions, completing questionnaires) or their request to withdraw from the study at any stage.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F90.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Attention-deficit hyperactivity disorder, predominantly inattentive type</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group will participate in a 24-session training program, each session lasting 60 minutes (30 minutes of neurofeedback + 30 minutes of yoga), conducted three times per week.    1. Sessions 1–3: Introduction and Initial AssessmentGoal: Reduce initial anxiety, familiarize children with the treatment process, and enhance motivation.Content:Neurofeedback: Baseline EEG assessment, introduction to the device, and simple games.Yoga: Introduction to yoga in child-friendly language, practice of abdominal breathing, and simple stretches.Homework: Daily 3-minute abdominal breathing exercise with parents.                                                                                                                                    2. Sessions 4–6: Beginning Basic TrainingGoal: Strengthen sustained attention and increase body awareness.Content:Neurofeedback: Implementation of SMR protocol (12–15 Hz), simple visual games.Yoga: Cat–cow, tree pose, and basic arm–leg stretches combined with calm breathing.Homework: Daily practice of the tree pose or a simple stretch at home.                                                                                                                                         3. Sessions 7–9: Stabilization and RelaxationGoal: Improve mental and physical self-regulation.Content:Neurofeedback: Continuation of SMR training with calm breathing before each session.Yoga: Focus on breathing and simple seated–standing movements.Homework: Daily 5-minute calm breathing practice with parents.                                                                  4. Sessions 10–12: Enhancing Selective AttentionGoal: Improve processing speed and focus on specific stimuli.Content:Neurofeedback: Introduction of low beta protocol (15–18 Hz), intermediate-level games.Yoga: Animal poses (frog, snake, bird) combined with storytelling.Homework: Practice one animal yoga pose at home and perform it for parents.                                                                                                             5. Sessions 13–15: Strengthening Sustained AttentionGoal: Enhance accuracy and mind–body control.Content:Neurofeedback: Combined SMR + beta protocol, more engaging games.Yoga: Balance exercises (tree pose, warrior, standing on one foot).Homework: Daily one-leg balance for 20 seconds.                                                                                                                         6. Sessions 16–18: Training in Simulated ConditionsGoal: Generalize learned skills to real-life situations.Content:Neurofeedback: Practice with distracting stimuli (additional sounds or images).Yoga: Guided relaxation (simple body scan, lying down, and breathing).Homework: Relaxation practice before bedtime (lying down and calm breathing).                                               7. Sessions 19–21: Review and IntegrationGoal: Automate attention and integrate mind–body skills.Content:Neurofeedback: Advanced-level games, focusing under more difficult conditions.Yoga: Integration of breathing, stretches, animal poses, and balance exercises.Homework: Short yoga session at home (5 minutes breathing + 2 simple poses).                               8. Sessions 22–24: Final ConsolidationGoal: Consolidate achievements and transfer skills into daily life.Content:Neurofeedback: Final review and training, reassessment of changes.Yoga: Review of learned movements, final playful yoga session.Homework: Continue daily practice (5 minutes breathing + one focus activity or yoga pose).</i_keyword>
      <i_keyword>Control group: They receive no training.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Attention-Deficit/Hyperactivity. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Integrated Visual and Auditory Continuous Performance Test.</prim_outcome>
      <prim_outcome>Children's Anxiety. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Spence Children's Anxiety Scale - SCAS.</prim_outcome>
      <prim_outcome>Attention-Deficit/Hyperactivity. Timepoint: Measurements will be conducted at pre-test, post-test, and three-month follow-up after the post-test. Method of measurement: Swanson, Nolan, and Pelham Rating Scale – Fourth Edition (SNAP-IV).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-09-03</approval_date>
        <contact_name>The Ethics Committee in Research of Islamic Azad University - Ahvaz Branch</contact_name>
        <contact_address>South Kargar Boulevard, Farhang Shahr, Golestan Highway Ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
